Literature DB >> 31712041

Novel imaging modalities in patients with uveitis.

Gábor Gy Deák1, Mei Zhou2, Anna Sporysheva2, Debra A Goldstein3.   

Abstract

Imaging is one of the key elements in the diagnosis and management of ocular diseases. This is particularly true of retinal conditions. In this review we discuss novel imaging modalities such as optical coherence tomography angiography (OCTA), choroidal optical coherence tomography (OCT), anterior chamber OCT, as well as widefield imaging modalities and fundus autofluorescence. We describe the advantages and shortcomings of these imaging modalities in comparison to the more traditional ones, as well as some common pitfalls. We also provide examples of how these newer imaging methods can aid clinicians in their decision making, and provide novel insights into disease pathogenesis.
Copyright © 2019 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31712041     DOI: 10.1016/j.jcjo.2019.06.005

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  3 in total

1.  Changes in choroidal imaging parameters following adalimumab therapy for refractory noninfectious uveitis.

Authors:  Ryuto Nishisho; Sentaro Kusuhara; Noriyuki Sotani; Kyong Woo Kim; Atsuko Katsuyama-Yoshikawa; Wataru Matsumiya; Kengo Akashi; Akio Morinobu; Makoto Nakamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-07       Impact factor: 3.117

2.  Incidence and changing patterns of uveitis in Central Tokyo.

Authors:  Takafumi Suzuki; Toshikatsu Kaburaki; Rie Tanaka; Shintaro Shirahama; Keiko Komae; Hisae Nakahara; Mitsuko Takamoto; Hidetoshi Kawashima; Makoto Aihara
Journal:  Int Ophthalmol       Date:  2021-05-28       Impact factor: 2.031

3.  Demography and clinical pattern of newly diagnosed uveitis patients in Malaysia.

Authors:  Rajasudha Sawri Rajan; Shelina Oli Mohamed; Mohamad Aziz Salowi
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.